Spatial variation in prostate cancer survival in the Northern and Yorkshire region of England using Bayesian relative survival smoothing

British Journal of Cancer

Volumn 99, Issue 11, 2008, Pages 1786-1793

  Fairley, L ^a   Forman, D ^a,b   West, R ^b   Manda, S ^c  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Bayesian analysis; Prostate cancer; Relative survival; Spatial models

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BAYES THEOREM; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DATA EXTRACTION; GEOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; ENGLAND; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 56749102782     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604757     Document Type: Article

References (32)

1. Bauvin E, Soulié M, Ménégoz F, Macé-Lesec'h J, Buémi A, Velten M, Villers A, Grosclaude P (2003) Medical and non-medical determinants of prostate cancer management: a population-based study. Eur J Cancer 39: 2364-2371
2. Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JW, Santaquilani M (2007) Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-1999: results of the EUROCARE-4 study. Lancet Oncol 8: 773-783
3. Besag J, York J, Mollie A (1991) Bayesian image restoration, with two applications in spatial statistics (with discussion). Ann Inst Statist Math 43: 1-75
4. Brewster DH, Fraser LA, Harris V, Black RJ (2000) Rising incidence of prostate cancer in Scotland: increased risk or increased detection. BJU Int 85: 463-473
5. Coleman MP, Rachet B, Woods LM, Mintry E, Riga M, Cooper N, Quinn MJ, Brenner H, Esteve J (2004) Trends in Socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 90: 1367-1373
6. Dickman PW, Coviello E, Hills M (2008) Estimating and modelling relative survival. http://www.pauldickman.com/survival/strs.pdf (accessed February 2008)
7. Dickman PW, Gibberd RW, Hakulinen T (1997) Estimating potential savings in cancer deaths by eliminating regional and social class variation in cancer survival in the Nordic countries. J Epidemiol Community Health 51: 289-298
8. Dickman PW, Sloggett A, Hills M, Hakulinen T (2004) Regression models for relative survival. Stat Med 23: 51-64
9. Ederer F, Axtell LM, Cutler SL (1961) The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 6: 101-121
10. Ellis L, Rachet B, Coleman MP (2007) Cancer survival indicators by cancer network: a methodological perspective. Health Stat Q 36: 36-41
11. Evans HS, Moller H (2003) Recent trends in prostate cancer incidence and mortality in Southeast England. Eur Urol 43: 337-341
12. Farrow DC, Samet JM, Hunt WC (1996) Regional variation in survival following the diagnosis of cancer. J Clin Epidemiol 49: 843-847
13. Gavin A, McCarron P, Middleton RJ, Savage G, Catney D, O'Reilly D, Keane PF, Murray LJ (2004) Evidence of prostate cancer screening in a UK region. BJU Int 93: 730-734
14. Hakulinen T, Tenkanen L (1987) Regression analysis of relative survival rates. J R Statist Soc C 36: 309-317
15. Hanna CL, Mason MD, Donovan JL, Barber JP (2002) Clinical oncologists favour radical radiotherapy for localized prostate cancer: a questionnaire survey. BJU Int 90: 558-560
16. Jarup L, Best N, Toledano M, Wakefield J, Elliot P (2002) Geographical epidemiology of prostate cancer in Great Britain. Int J Cancer 97: 695-699
17. Henderson R, Shimakura S, Gorst D (2002) Modelling spatial variation in leukemia survival data. J Am Statist Ass 97: 965-972
18. Krupski TL, Kwan L, Afifi AA, Litwin MS (2005) Geographic and socio-economic variation in the treatment of prostate cancer. J Clin Oncol 23: 7881-7888
19. Melia J, Moss S, Johns L (2004) Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study. BJU Int 94: 51-56
20. National Institute for Clinical Excellence (2002) Guidance on Cancer Services: improving outcomes in urological cancers - the manual. http://www.nice.org.uk/nicemedia/pdf/Urological_Manual.pdf
21. Nobel M, Wright G, Dibben C, Smith GAN, McLenna D, Anttila C, Branes H, Mokhtar C, Nobel S, Avenell D, Gardner J, Covizzi I, Lloyd M (2004) Indices of Deprivation 2004. Report to the Office of the Deputy Prime Minister. Neighbourhood Renewal Unit: London
22. NYCRIS reference data 2004 (2004) www.nycris.org.uk (accessed February 2008)
23. NYCRIS (2007) Cancer in the 21st Century. NYCRIS Statistical Report for 2000-2004, www.nycris.org.uk
24. Osnes K, Aalen OO (1999) Spatial smoothing of cancer survival: a Bayesian approach. Stat Med 18: 2087-2099
25. Payne HA, Gillatt DA (2007) Differences and commonalities in the management of locally advanced prostate cancer: results from a survey of oncologists and urologists in the UK. BJU Int 99: 545-553
26. Pohar M, Stare J. (2006) Relative survival analysis in R. Comput Methods Programs in Biomed 81: 272-278
27. Post PN, Damhuis RAM, Van der Meyden APM, EUROCARE Working Group (1998) Variation in survival of patients with prostate cancer in Europe since 1978. Eur J Cancer 34: 2226-2231
28. Rachet B, Coleman MP (2004) Cancer Survival indicators for the National Health Service in England: exploration of alternative geographic units of analysis - the Primary Care Organisation and Strategic Health Authority. London School of Hygiene and Tropical Medicine 2004
29. Spiegelhalter DJ, Best NG, Carlin BP, Van der Linde A (2002) Bayesian measures of model complexity and fit (with Discussion). J R Statist Soc B 64: 583-616
30. Spiegelhalter DJ, Thomas A, Best NG, Lunn D (2004) BUGS: Bayesian Inference Using Gibbs Sampling, Version 1.4.1 Medical Research Council Biostatistics Unit, Cambridge University 2004, www.mrc-bsu.cam.ac.uk/bugs/ winbugs/manual14.pdf (accessed October 2008).
31. The EUROCARE Working Group (2003) EUROCARE-3: survival of cancer patients diagnosed 1990-1994 - results and commentary. Ann Oncol 14: v61-v118
32. Yu XQ, O'Connell DL, Gibberd RW, Smith DP, Dickman PW, Amrstrong BK (2004) Estimating regional variation in caner survival: a tool for improving cancer care. Cancer Causes Control 15: 611-618